Today: 9 June 2026
Uber stock jumps after CES robotaxi debut with Lucid, Nuro as AV race heats up

Uber stock jumps after CES robotaxi debut with Lucid, Nuro as AV race heats up

New York, Jan 6, 2026, 12:56 EST — Regular session

  • Uber shares rose in Tuesday trading after unveiling a production-intent robotaxi with Lucid and Nuro at CES
  • The partners said testing began in December ahead of a planned Bay Area launch later this year
  • The move follows a fresh “sell” call that flagged rising robotaxi competition in 2026

Uber Technologies’ shares rose about 5% to $84.93 in midday trading on Tuesday after it and partners Lucid Group and Nuro unveiled a production-intent robotaxi at the CES tech show in Las Vegas. The vehicle uses Nuro’s Level 4 system — meaning it can drive itself in limited areas without a human — and runs on Nvidia’s DRIVE AGX Thor computer, the companies said. Uber, which sold its self-driving unit to Aurora Innovation in 2020, said testing began in December ahead of a planned launch in the San Francisco Bay Area later this year, as Alphabet’s Waymo and Tesla expand their own robotaxi efforts.

The announcement is the latest sign that autonomous rides are shifting from pilot programs to commercial rollouts in big U.S. cities. For Uber, the prize is volume on its app, but investors are also weighing what a driverless future means for its take rate, the share of each fare the company keeps.

Uber shares slid on Monday after Melius Research downgraded the stock to “sell” and cut its price target to $73, arguing that competition in autonomous vehicles will heat up this year. “The world is moving quick and AV competition is set to intensify in 2026,” analysts Conor Cunningham and Patrick Coleman wrote. Barron’s

Uber said the robotaxi will feature an Uber-designed in-cabin experience, including an in-vehicle visualization that shows what the vehicle sees and its planned path in real time. “Uber is proud to partner with Lucid and Nuro to bring a state-of-the-art robotaxi to market later this year,” said Sarfraz Maredia, Uber’s global head of autonomous mobility and delivery. The company said the program combines on-road, closed-course and simulation testing, with production expected to start at Lucid’s Arizona factory pending final validation. Uber Investor Relations

Uber closed down 2.6% on Monday at $80.74, leaving the stock about 21% below its 52-week high of $101.99 set on Sept. 22, according to MarketWatch data. Tuesday’s gain put the shares back above $84, but traders have kept a tight focus on autonomy headlines after a volatile start to the year.

Still, robotaxis carry long lead times and heavy regulatory and safety hurdles, and any high-profile incident could slow deployments. The economics are also untested: Uber may have to share more revenue with vehicle and software partners than it does with human drivers, muting the upside for margins.

Traders will look for more detail on rollout timing and commercial terms as CES continues this week and for clues on how quickly partnerships can translate into bookings growth. Uber has not announced a date for its next earnings report, but Wall Street Horizon forecasts results on Feb. 4, before the bell.

Stock Market Today

  • Washington's Railroad Rule Changes Threaten U.S. Supply Chain
    June 9, 2026, 9:15 AM EDT. Congress and the White House are quietly imposing new regulations on U.S. railroads, a critical component of the national economy. These changes, seen as micromanagement, could disrupt freight movement and supply chains. The timing raises concerns amid ongoing economic pressures and recovery efforts post-pandemic. Rail networks handle bulk goods and industrial materials vital to commerce. Industry experts warn that increased federal oversight may hinder operational efficiency and investment. Delays or inefficiencies in rail transport could ripple through markets, affecting costs and delivery times across sectors. Stakeholders urge a balanced approach to regulation to ensure infrastructure resilience without stifling rail companies' flexibility and growth.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure
Previous Story

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Merck stock hits 52-week high as vaccine policy shift and JPM conference loom
Next Story

Merck stock hits 52-week high as vaccine policy shift and JPM conference loom

Go toTop